Thorsten von Goessel Thorsten von Goessel 在工程和設施部門任職的 Thorsten von Gossel 講到,百靈佳殷格翰是一家有長遠願景和完好領導團隊的家族企業。
Dr. Hsing-Jung Chen-Engerer Dr. Hsing-Jung Chen-Engerer Hsing-Jung Chen-Engerer 博士談到他在百靈佳殷格翰的研究與開發部門充實的職業生涯。
Could decentralised trials transform the way we view depression? Could decentralised trials transform the way we view depression? Could decentralised trials transform the way we view depression? Dr Vikas Mohan Sharma believes this could deliver meaningful changes for patients all arround.
A future without pills – could AI change the way we treat psychiatric diseases? A future without pills – could AI change the way we treat psychiatric diseases? Dr Cornelia Dorner-Ciossek talks about how her work with smartphone tech could transform how we treat mental illness.
Are combination therapies the answer to battling KRAS cancers? Are combination therapies the answer to battling KRAS cancers? Dr Ulrich Dünzinger and Kristie Fernamberg talk about their work with the SOS1 KRAS inhibitor to block tumour-triggering signal
Innovation from within Innovation from within Justine Rochon and Marc Weimer talk about the transformation of Biostatistics and Data Sciences (BDS) into a modern organisation in drug development.
Candice is moving to Germany Candice is moving to Germany Are you considering a career at Boehringer Ingelheim? Find out why Candice loves working here. For more talent insights, visit our Careers Page.
Leticia develops product medical strategies Leticia develops product medical strategies Leticia develops product medical strategies at Boehringer Ingelheim. For more talent insights, visit our Careers Page.